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Abstract
The objective of this systematic review was to evaluate the efficacy of antibiotics to prevent or
control colibacillosis in broilers. Studies found eligible were conducted controlled trials in
broilers that evaluated an antibiotic intervention, with at least one of the following outcomes:
mortality, feed conversion ratio (FCR), condemnations at slaughter, or total antibiotic use.
Four electronic databases plus the gray literature were searched. Abstracts were screened for
eligibility and data were extracted from eligible trials. Risk of bias was evaluated.
Seven trials reported eligible outcomes in a format that allowed data extraction; all reported
results for FCR and one also reported mortality. Due to the heterogeneity in the interventions
and outcomes evaluated, it was not feasible to conduct meta-analysis.
Qualitatively, for FCR, comparisons between an antibiotic and an alternative product did
not show a significant benefit for either. Some of the comparisons between an antibiotic and a
no-treatment placebo showed a numerical benefit to antibiotics, but with wide confidence
intervals. The risk-of-bias assessment revealed concerns with reporting of key trial features.
The results of this review do not provide compelling evidence for or against the efficacy of
antibiotics for the control of colibacillosis.
Introduction
Rationale
Escherichia coli (E. coli) are a diverse group of bacteria that are a normal part of poultry
microflora. E. coli are found throughout the intestinal and upper respiratory tracts, as well
as on the skin and feathers of healthy birds (Nolan et al., 2013). Although most strains of
E. coli are not detrimental to bird health, some are capable of causing disease outside of the
intestinal tract. Those that are capable of causing disease in birds, or cause disease when
host defenses have been impaired, are referred to as avian pathogenic E. coli (APEC) (Dziva
and Stevens, 2008). Colibacillosis refers specifically to a localized or systemic infection caused
by an APEC and is a leading cause of morbidity and mortality in the global poultry industry
(Guabiraba and Schouler, 2015). Syndromes of APEC-associated disease include coliseptice-
mia, hemorrhagic septicemia, coligranuloma (Hjarre’s disease), airsacculitis (chronic respira-
tory disease, CRD), swollen head syndrome, polyserositis, enteritis, venereal colibacillosis,
coliform cellulitis (inflammatory or infectious process, IP), peritonitis, salpingitis, orchitis,
osteomyelitis/synovitis (including turkey osteomyelitis complex), panophthalmitis, and
omphalitis/yolk sac infection (Barnes et al., 2008; Nolan et al., 2013; Guabiraba and
Schouler, 2015). Colibacillosis can develop as a primary infection, or as a secondary infection
alongside other viral or bacterial pathogens (Nolan et al., 2013).
Prevention and control of colibacillosis can be challenging, as E. coli are part of the normal
intestinal flora of birds, and approaches that focus on management strategies have limited
success. Approaches to prevention of colibacillosis include biosecurity to manage access of
personnel and the movement of birds to limit the introduction of pathogenic E. coli and reduce
exposure of the flock. Ensuring adequate environmental sanitation and optimal climate con-
ditions, such as humidity, ventilation, and temperature can also help minimize pathogen
growth in the flock and reduce the numbers of E. coli in the water and feed. In addition,
protecting flocks from other bacterial or viral infections that can decrease host resistance
can reduce the risk of colibacillosis (Nolan et al., 2013).
Antibiotics are also used for APEC, either in flocks where the
birds are not diseased but may at risk of illness in order to prevent
illness (prophylaxis) or in flocks where some birds are already ill
with the intention to prevent further illness or mortality (meta-
phylaxis) (Singer and Hofacre, 2006). Current challenges in the
prevention and control of colibacillosis include the limited
availability of drugs and the emergence of strains that are highly
virulent and resistant due to virulence and resistance plasmids
(Johnson et al., 2005, 2006).
There is a global consensus that antibiotics should be used
prudently in humans and animals to reduce the risk of antimicro-
bial resistance; both the World Health Organization (WHO) and
the World Organization for Animal Health (OIE) have published
recommendations on the judicious use of antimicrobials in
response to the threat of antimicrobial resistance (WHO, 2015;
OIE, 2018). In order to reduce antibiotic use, veterinarians and
poultry specialists need access to unbiased, and accurate evidence
regarding the efficiency of antimicrobials for the prevention and
control of colibacillosis in broilers. Such information enables
informed comparisons between the benefits and the harms asso-
ciated with various antibiotics, which in turn allows practitioners
to select the most appropriate and effective preventive applica-
tions or treatments.
Systematic reviews provide a rigorous and transparentmethod of
identifying and summarizing the available literature to address
a specific question related to the efficacy of an intervention
(European Food Safety Authority, 2010; Higgins and Green, 2011;
O’Connor and Sargeant, 2014; Sargeant and O’Connor, 2014).
Systematic reviews follow defined steps and require the involvement
of multiple reviewers at each stage to reduce the potential for bias.
When sufficient data exist, the results from multiple studies can
be combined in a statistical meta-analysis to provide a summary
measure of the effect size of an intervention across studies
(Higgins and Green, 2011; O’Connor et al., 2014). Where there
are multiple treatment options for a specific disease or condition,
a network meta-analysis (NMA) provides a method for evaluating
the comparative efficacy of the treatment choices (Salanti, 2012).
Research synthesis methods such as systematic reviews, meta-
analyses, and NMA are therefore powerful tools that can provide
scientifically valid information about the scope and conclusions
of the existing literature on preventive approaches to colibacillosis
in broiler poultry; these syntheses can in turn support evidence-
based decision-making by managers and practitioners.
Objectives
Our objective was to conduct a systematic review and a network
meta-analysis, if supported by the data, to address the following
review question: ‘What is the efficacy of antibiotics to prevent
or control colibacillosis in broiler chickens?’
Methods
Protocol and registration
An a priori protocol for this review was prepared and is archived in
the University of Guelph’s institutional repository (The Atrium;
https://atrium.lib.uoguelph.ca/xmlui/handle/10214/14349). The
protocol was also published online on the Systematic Reviews for
Animals and Food (SYREAF) website (available at http://www.
syreaf.org/). The review protocol was reported in accordance with
PRISMA-P guidelines (Moher et al., 2015), and this systematic
review is reported in accordance with the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA) state-
ment guidelines (Liberati et al., 2009; Moher et al., 2009).
Eligibility criteria
Primary research studies available in English were eligible for inclu-
sion in the systematic review. In addition, studies must have been
conducted in broiler chickens (the target population) and must
have evaluated an antibiotic regime licensed for use in broilers
in ovo, by injection, in feed, or in drinking water at doses consistent
with therapeutic or prophylactic use (target intervention). Studies
must have compared the antibiotic intervention to a placebo, an
untreated control group, a non-antibiotic intervention, or a differ-
ent antibiotic treatment. In the protocol, the eligible antibiotic
regimes included any antibiotic used in treating or preventing
colibacillosis in poultry that is included in the OIE list of approved
antimicrobial agents of veterinary importance (OIE, 2015), regard-
less of their importance to humanmedicine. However, this was later
modified to include any antibiotic regime included in a published
study, due to the difference in approved antibiotic regimes over
time and among countries. Eligible studies must have examined
at least one of the following outcomes: mortality, feed conversion
ratio (FCR), condemnations at slaughter due to colibacillosis, or
total antibiotic use. Although FCR is a performance measure, it
was included as an eligible outcome because it is likely to reflect
the clinical and subclinical disease experience of a flock. Only
controlled trials with natural disease exposure were eligible for
inclusion, although we documented the number of controlled trials
with deliberate disease challenge and the number of analytical
observational studies evaluating eligible interventions and out-
comes that were captured during the full-text screening stage.
Information sources
The databases searched were MEDLINE (via PubMed; 1946 to
date of search), CAB Abstracts (via the University of Guelph
CAB interface; 1900 to date of search), Science Citation Index
and Conference Proceedings Citation Index – Science (via Web
of Science; 1900 to date of search), and AGRICOLA (via
ProQuest; 1970 to date of search). Additionally, a single reviewer
hand-searched the proceedings of the Western Poultry Disease
Conference (1980–2018) and the section of the United States
Food and Drug Administration website dedicated to recent
animal drug approvals for relevant data.
Search
Initially, the search strategy was designed around the concepts of
poultry, antibiotic interventions, colibacillosis, and antibiotics to
exclusively capture primary studies that examined prophylactic
uses of antibiotics to prevent colibacillosis in poultry. However,
during preliminary screening, articles were identified in which
antibiotic interventions were applied as metaphylaxis to control
colibacillosis (i.e. to prevent further illness or death in flocks
where colibacillosis infections were present in some birds). In
these instances, the authors referred to the interventions as ‘treat-
ment for disease,’ The American Veterinary Medical Association
defines ‘disease control’ at the population level as the use of anti-
microbials to reduce the incidence of illness in groups of animals
where some are already showing signs of disease or infection
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and ‘disease treatment’ at the population level as administration
of an antimicrobial to those animals within the group with
evidence of disease (https://www.avma.org/KB/Policies/Pages/
AVMA-Definitions-of-Antimicrobial-Use-for-Treatment-Control-
and-Prevention.aspx). The terminology used in the colibacillosis
literature is not entirely consistent with the AVMA definitions,
while noting that these concepts may not have been as explicitly
defined at the time of publication of all of the relevant articles. We
therefore deviated from the review protocol and modified the
search to include search terms related to antibiotic use for preven-
tion, control, or treatment, regardless of the specific terminology
used by the authors. The updated search was conducted on 28
October 2018 through the University of Guelph, Canada. The
searches were not limited by date, language, or publication type.
Table 1 shows the modified search strategy as it was applied in
the Science Citation Index database (via the Web of Science plat-
form). The search string formatting was modified as needed to
reflect differences in database interfaces for each of the remaining
databases.
Search results were uploaded to EndNoteX7 (Clarivate
Analytics, Philadelphia, PA) and duplicate citations were
removed. Citations were then uploaded to the systematic review
management software DistillerSR (Evidence Partners Inc.,
Ottawa, ON) and additional duplicates were removed. When
the same data were presented in both a conference proceeding
and a journal article, the conference proceeding was removed.
Study selection
DistillerSR was used to manage the screening, data extraction, and
risk of bias assessment stages of the review. Initially, titles and
abstracts of all citations identified in the search were screened
for eligibility. All reviewers had training in epidemiology and
systematic review methods, and all reviewers participated in a pre-
test of the first 250 titles and abstracts to resolve any uncertainties
about the wording of the screening questions. Thereafter, two
reviewers independently evaluated each citation. The following
questions were used to assess relevance:
(1) Is this a primary study evaluating the use of one or more
antibiotics to prevent or treat* colibacillosis in broilers?
[* question wording differs from the protocol, based on a
protocol deviation to allow metaphylactic use in infected
flocks to be included as eligible]
YES, NO (EXCLUDE), UNCLEAR
(2) Is there a concurrent comparison group? (i.e. controlled trial
with natural or deliberate disease exposure or analytical
observational study)
YES, NO (EXCLUDE), UNCLEAR
(3) Is the full text available in English?
YES (include for full-text screening), NO (EXCLUDE),
UNCLEAR (include for full-text screening)
Citations were excluded if both reviewers responded ‘no’ to any
of the screening questions. Disagreements whether to include or
exclude were resolved by consensus. If consensus could not be
reached, the article was marked as ‘unclear’ and advanced to full-
text screening.
Following the title and abstract screening, full-text articles were
retrieved and were subject to additional eligibility screening. Two
reviewers independently evaluated the full-text articles, with
agreement required at the question level. Any disagreements
were resolved by consensus, or if consensus could not be reached,
a third reviewer arbitrated the decision. All reviewers conducted a
pre-test on the first ten full-texts to ensure that all eligibility ques-
tions were clear. The same three questions that were applied at the
title and abstract screening level were applied again in the full-text
screening, but reviewers could select only ‘yes’ (neutral) or ‘no’
(EXCLUDE). The full-text screening form also included the
following questions:
(1) Is the full text available with >500 words? YES, NO
(EXCLUDE)
(2) Does the study assess the use of any antibiotic intervention
for the prevention of colibacillosis or pathogenic E. coli, either
as prophylaxis in healthy birds or as metaphylaxis to prevent
further illness/death when colibacillosis is present in the flock?
YES, NO (EXCLUDE) [Italics represent deviations from the
original protocol]
(3) Are at least one of the following outcomes described: mortal-
ity, FCR, condemnations due to colibacillosis, or total anti-
biotic use? YES, NO (EXCLUDE)
Table 1. Full electronic search string used to identify studies examining the prevention or treatment of colibacillosis in broilers as applied in the Science Citation
Index (via Web of Science) on 28 October 2018
#1 TS = (Chicken* OR Poultry* OR flock* OR gallus* OR broiler*) 194,481
#2 TS = (medicat* OR antimicrobial* OR ‘anti-microbial*’ OR antibiotic* OR ‘anti-biotic*’ OR antibacterial* OR ‘anti-bacterial*’ OR antiinfect* OR
‘anti-infect*’ OR bacteriocid* OR bactericid* OR microbicid* OR ‘anti-mycobacteri*’ OR antimycobacteri*)
802,537
#3 TS = (apramycin OR amoxicillin OR Avilamycin OR enrofloxacin OR Neomycin OR Neomicin OR salinomycin OR salinomicin OR spectinomycin
OR Sulfaquinoxaline OR ceftiofur OR gentamycin OR gentamicin OR lincomycin OR oxytetracycline OR Bacitracin OR Sulfadimethoxine OR
Sulfaquinoxaline OR Virginiamycin OR Chlortetracycline OR Tylosin OR Tetracycline OR Trimethoprim OR Virginiamycin OR Sulfamethoxazole)
109,508
#4 TS = (Apralan OR Baytril OR paracillin OR Garasol OR Lincosol OR Lincomix OR Coban OR Monteban OR Neo-chlor OR neo-tetramed OR
NeoMed OR Neotet OR oxy OR oxysol OR sacox OR posistac OR coxistac OR Sulforal OR Sulfadived OR di-methox OR Onycin OR tetra OR
tetramed OR Stafac OR ‘Super Booster’ OR Uniprim OR Tylan)
59,567
#5 TS = (colibacillosis OR coli OR Escherichia OR coliform OR colisepticaemia OR colisepticemia OR coligranuloma OR Hjarre’s OR ‘air sac
disease’ OR cellulitis OR peritonitis OR osteomyelitis OR ‘brittle bone disease’ OR peritonitis OR salpingitis OR synovitis OR omphalitis OR
enteritis OR ‘hemorrhagic septicemia’ OR ‘chronic respiratory disease’ OR ‘swollen head syndrome’ OR ‘venereal colibacillosis’ OR ‘coliform
cellulitis’ OR ‘yolk sac infection’ OR ‘APEC’ or ‘pathogenic E. coli’)
585,742
#6 TS = (prophyla* OR metaphyla* OR ‘meta-phyla*’ OR ‘mass treatment’ or ‘mass medication’ or ‘blanket medication’ or ‘blanket treatment’
OR prevent* OR ‘in feed’ OR ‘in-feed’ OR ‘in-water’ OR ‘in water’ OR ‘medicated’ OR ‘in ovo’ OR treatment OR medicat*)
5,843,139
#1 AND (#2 OR #3 OR #4) AND #5 AND #6 1394
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(4) Eligible study design: Is the study a controlled trial with nat-
ural disease exposure? YES (moves to data extraction stage),
NO, the study is a controlled trial with deliberate disease
induction (indicate the antibiotic(s) evaluated, but exclude
from data extraction) NO, the study is an observational
study (indicate the antibiotic(s) evaluated, but exclude from
data extraction)
Data collection process
Two reviewers used a standardized form to extract data from all
citations that met the full-text screening criteria. Nested forms
were created in DistillerSR to facilitate data extraction for multiple
intervention comparisons or outcomes within a trial. All reviewers
were trained in the use of nested forms, and all reviewers piloted
the forms on the first five articles to ensure consistency.
Discrepancies in data extraction were resolved by consensus, or




Study-level data extracted included year and country of conduct,
months of data collection, setting (research or commercial flock
(s)), strain of birds, sex of birds, number of flocks/farms enrolled,
inclusion criteria at the flock level, rearing conditions (conven-
tional, organic, antibiotic-free) and whether the treatment was
given as prophylaxis (all birds free of colibacillosis at the start
of treatment) or as metaphylaxis (some birds ill at the time of
treatment initiation). These definitions are consistent with the
American Veterinary Medical Association (AVMA) definitions
of antimicrobial use for prevention and treatment (AVMA,
2019). Data on study characteristics were extracted for all studies
included after the full-text screening. Further data on the effect
sizes of the interventions were only collected, and risk of bias
assessment was only undertaken if sufficient data were presented
for one or more of the eligible outcomes.
Intervention details
Details on the interventions evaluated in each study were
recorded, including a description of the intervention (antibiotic
name, dose, route, and frequency of administration), a description
of the comparison group(s), the number of birds, and flocks
enrolled, the length of follow-up, any losses to follow-up, and
descriptions of concurrent treatments.
Eligible outcomes
Outcomes eligible for data extraction were mortality, FCR, con-
demnations at slaughter due to colibacillosis, and total antibiotic
use. For each outcome reported in a study, if an adjusted
summary effect was presented (adjusted odds ratio (OR) or risk
ratio (RR) if the outcome was binary, or least square mean differ-
ences if the outcome was continuous), these data were extracted.
Variables included in the adjustment and the corresponding
precision estimates were recorded. If an adjusted measure was
not reported, unadjusted summary effect size (second priority)
or arm-level data (third priority) were recorded along with applic-
able variance components. Data were not extracted if they were
presented without variance measures and if a measure of variance
could not be calculated.
Risk of bias in individual studies
The Cochrane Risk of Bias tool for RandomizedTrials (RoB 2.0, 2016
version) was used to assess the risk of bias at the outcome level for all
outcomes with extracted data (Higgins et al., 2016). Signaling ques-
tions were modified for the use in livestock and poultry trials. The
following domains of bias were assessed: bias arising from the
randomization process, bias due to deviations from the intended
interventions, bias due tomissing outcome data, bias in themeasure-
ment of the outcome, and bias in the selection of reported results. In
the Cochrane risk of bias instrument, a single question in the ‘bias
due to randomization’ domain asks whether the authors described
the method for generating the random sequence. We modified this
question to include a response category for studies in which the
authors reported that allocation to the intervention groups was ‘ran-
dom,’ but did not provide details on the actual method for generating
the random sequence. Under the risk of bias domain related to devia-
tions from the intended intervention, there is a question on whether
the participants were aware of their assigned interventions; in the
present review, the ‘participants’ in all applicable trials were broiler
chickens, and so this question was always answered as ‘no’.
Another question under this domain asks whether study personnel
were blinded; for the purposes of this review, the animal caregivers
were considered to be the relevant study personnel.
The overall risk of bias within each domain was calculated as
per Higgins et al. (2016), with one exception: for bias due to
the randomization process domain, we did not include allocation
concealment in the algorithm because all animals within a flock
are included in the type of trial involved in this review. Further,
it is unlikely that a producer or investigator would have any treat-
ment preference for a given flock, as the differential economic
value of a flock would not be known at the time of allocation.
This approach has been used in a previous synthesis study evalu-
ating the risk of bias in livestock trials (Moura et al., 2019).
Summary measures
An effect size (OR or mean difference) was calculated for the results
from individual studieswhere the datawere presented at the arm level
(i.e. raw data on the number of events and the total number of obser-
vations for each intervention group were reported). For binary data
reported at the arm level, the OR and 95% confidence intervals
were calculated using Epi Tools Epidemiological Calculators, avail-
able at: http://epitools.ausvet.com.au/content.php?page=2by2Table.
For continuous data presented at the arm level, the mean difference
and confidence intervals were calculated using OpenEpi, available at:
https://www.openepi.com/Mean/t_testMean.htm.
Synthesis of results
As described in the protocol, the intention of this review was to
conduct a network meta-analysis. However, due to the heterogen-
eity of the interventions and outcomes in the eligible studies that
were captured in the search, no quantitative synthesis was per-
formed. Trial results were presented in a forest plot for purposes
of visualization, but no summary measure was calculated and het-
erogeneity was not formally assessed.
Risk of bias across studies
Risk of bias across studies (‘publication bias’) is usually evaluated
by examining a funnel plot examination for small-study effects
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using pairwise comparisons. Two steps generally are recom-
mended: a visual evaluation of the symmetry in the funnel plots,
and a formal statistical test for symmetry, if sufficient data are avail-
able (>10 studies) (Higgins and Green, 2011). In this dataset, too
few observations were available for each intervention, so any assess-
ments of symmetry could not be reliable. Therefore, an evaluation
of the risk of bias across studies was not conducted.
Additional analyses
No additional analyses were conducted.
Results
Study selection
Of the 3425 unique citations identified by the search, 301 were
advanced to the full-text screening (Fig. 1). There were 73 articles
at the full-text screening stage that evaluated antibiotics in broilers
and included at least one eligible outcome, but ultimately were
excluded because they involved a deliberate disease exposure
(i.e. challenge trials). No observational studies with relevant expo-
sures and outcomes were identified. Nine controlled trials with
natural disease exposure were included in the review.
Study characteristics
The study characteristics for the eligible trials are shown in Table 2.
Reporting of the characteristics of interest was not complete for
some trials, particularly concerning the months and years during
which some trials were conducted. The included trials were con-
ducted in several countries in both commercial and research flocks.
The majority of studies (n = 8/9) were conducted in a single flock.
Seven trials reported FCR (Jamroz et al., 2003; Olnood et al., 2007;
Baurhoo et al., 2009; Viveros et al., 2011; Amerah et al., 2012;
Bostami et al., 2016; Vineetha et al., 2017), and one trial also
reported mortality (Amerah et al., 2012). Two trials reported
Fig. 1. Flow diagram illustrating the selection of eligible studies for a systematic review of the efficacy of antibiotics for the prevention and treatment of coliba-
cillosis in broilers.
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assessment of one or more relevant outcomes, but the datawere not
presented in a form that could be extracted (Cracknell et al., 1986;
Huff et al., 2004). In all of the studies with extractable data, antibio-
tics were used prophylactically (i.e. for the prevention of
colibacillosis).
Risk of bias within studies
Six of the seven trials with one or more outcomes assessed for bias
reported the use of random allocation to treatment group (Jamroz
et al., 2003; Olnood et al., 2007; Baurhoo et al., 2009; Amerah et al.,
2012; Bostami et al., 2016; Vineetha et al., 2017), although none
provided information on the method used to generate the random
sequence. For the remaining domains of bias, none of the trials
provided the information necessary to evaluate the potential
risks of bias, and therefore there were ‘some concerns’ about the
potential risk of bias for all bias domains for all outcomes.
Results of individual studies
The most commonly reported outcome was FCR, which was eval-
uated in seven trials with a total 25 treatment comparisons with at
least one eligible antibiotic (Jamroz et al., 2003; Olnood et al.,
2007; Baurhoo et al., 2009; Viveros et al., 2011; Amerah et al.,
2012; Bostami et al., 2016; Vineetha et al., 2017) (Table 3).
Results were presented at the arm level for all of the trials and
thus the effect sizes shown in Table 3 were calculated post hoc.
The antibiotics evaluated in one or more treatment comparisons
were bacitracin (four studies, 14 comparisons), virginiamycin
(one study, three comparisons), avoparacin (one study, three com-
parisons), chlortetracycline (one study, two comparisons), and
avilamycin (two studies, two comparisons). Comparison groups
varied but included groups receiving no intervention, various pro-
biotic products, mannan-oligosaccharides, herbal mixtures, grape
derivatives, and one direct comparison of different antibiotics. All
interventions in all trials were applied at the group (flock) level.
Comparisons for FCR are shown in Fig. 2. None of the compar-
isons between an antibiotic intervention and an alternative
intervention showed a benefit of one intervention over another.
The comparisons between an antibiotic and a no-treatment con-
trol group showed numeric benefits of the antibiotic treatment,
although many of the confidence intervals were wide and gener-
ally included the null value. The heterogeneity among specific
interventions and comparators precluded a quantitative summary
of antibiotic efficacy, and thus no summary effect or evaluation of
heterogeneity is included in Fig. 2.
None of the included trials reported results for condemnations
at slaughter due to colibacillosis, and none of the trials reported
total antibiotic use by the group. A single trial reported mortality
outcomes for two comparisons: one between a group receiving
bacitracin methylene disalicylate and a no-treatment control
group, and another between the antibiotic group and a probiotic
control group (Amerah et al., 2012) (Table 3). The results of both
comparisons had corresponding confidence intervals that
included the null value.
Synthesis of results
The research synthesis approach proposed in the protocol was not
conducted due to the sparsity of data available to address the
review question.
Risk of bias across studies





Although antibiotic use in the poultry industry has decreased
significantly as a result of the Veterinary Feed Directive (VFD;
Table 2. Characteristics of eligible trials investigating the efficacy of antibiotics for the prevention and treatment of colibacillosis in broilers
Study Country Setting
Month and year
conducted Strain of birds Sex # flocks Eligible outcomes




NR Ross 308 Male 1 Mortality, Feed
conversion ratio
(FCR)
Baurhoo et al. (2009) Canada Commercial
flock(s)
NR Cobb 500 Male 1 FCR
Bostami et al. (2016) Korea Commercial
flock(s)
NR Ross Mixed 1 FCR








Huff et al. (2004) NR NR NR Cobb 500 Male 1 NA
Jamroz et al. (2003) NR NR NR Hybro HI-YR Mixed 1 FCR
Olnood et al. (2007) Australia NR NR Cobb Male 1 FCR





NR NR 1 FCR
Viveros et al. (2011) NR NR NR Cobb Male 1 FCR
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Table 3. Intervention arms and results for studies included in a systematic review of the efficacy of antibiotics for the prevention and treatment of colibacillosis in broilers














Bacitracin methylene disalicylate, in feed,
50 mg kg−1 feed
350 (7) No treatment 350 (7) 41 −0.04 (−0.09, 0.003)
Bacitracin methylene disalicylate, in feed,
50 mg kg−1 feed
350 (7) Probiotic, in feed, 7.5 × 104 cfu g−1 350 (7) 41 −0.02 (−0.03, 0.07)
Baurhoo et al.
(2009)
Virginiamycin, in feed, 16.5 mg kg−1 feed 165 (3) Mannanoligosaccharide (0.5%), in feed 165 (3) 37 0.06 (−0.02, 0.14)
Bacitracin, in feed, 55 mg kg−1 feed 165 (3) Mannanoligosaccharide (0.5%), in feed 165 (3) 37 0.04 (−0.04, 0.12)
Virginiamycin, in feed, 16.5 mg kg−1 feed 165 (3) Mannanoligosaccharide (0.2%), in feed 165 (3) 37 0.03 (−0.05, 0.11)
Bacitracin, in feed, 55 mg kg−1 feed 165 (3) Mannanoligosaccharide (0.2%), in feed 165 (3) 37 0.01 (−0.07, 0.09)
Bacitracin, in feed, 55 mg kg−1 feed 165 (3) No treatment 165 (3) 37 −0.03 (−0.11, 0.05)
Bacitracin, in feed, 55 mg kg−1 feed 165 (3) Virginiamycin, in feed, 16.5 mg kg−1 feed 165 (3) 37 −0.02 (−0.10, 0.06)
Virginiamycin, in feed, 16.5 mg kg−1 feed 165 (3) No treatment 165 (3) 37 −0.01 (−0.09, 0.07)
Bostami et al.
(2016)
Chlortetracycline-HCl, in feed, 0.1% (W/W) 100 (10) Probiotic, in feed 100 (10) 34 0.02 (−0.05, 0.09)
Chlortetracycline-HCl, in feed, 0.1% (W/W) 100 (10) No treatment 100 (10) 34 −0.11 (−0.18, −0.03)
Jamroz et al.
(2003)
Avilamycin, in feed, 10 ppm 280 (5) Herbal mixture, in feed, 150 ppm 280 (5) 47 0.02 (−0.11, 0.05)
Avilamycin, in feed, 10 ppm 280 (5) Herbal mixture, in feed, 300 ppm 280 (5) 47 0.01 (−0.20, 0.40)
Avilamycin, in feed, 10 ppm 280 (5) No treatment 280 (5) 47 −0.04 (−0.07, 0.01)
Olnood et al.
(2007)
Zinc-bacitracin in feed, 50 ppm 49 (7) Probiotica, in feed 49 (7) 41 −0.02 (−0.08, 0.04)
Zinc-bacitracin in feed, 50 ppm 49 (7) Probioticb, in feed 49 (7) 41 −0.01 (−0.07, 0.05)
Zinc-bacitracin in feed, 50 ppm 49 (7) No treatment 49 (7) 41 −0.02 (−0.08, 0.04)
Zinc-bacitracin in feed, 50 ppm 49 (7) Probioticc, in feed 49 (7) 41 0.00 (−0.06, 0.06)
Zinc-bacitracin in feed, 50 ppm 49 (7) Probioticd, in feed 49 (7) 41 0.01 (−0.05, 0.07)
Vineetha et al.
(2017)
Bacitracin methylene disalicylate, in feed, 20 g
100 kg−1 feed
40 (5) Probiotice in feed 40 (5) 35 0.00 (−0.03, 0.03)
Bacitracin methylene disalicylate,in feed, 20 g
100 kg−1 feed
40 (5) No treatment 40 (5) 35 −0.03 (−0.06, −0.002)
Bacitracin methylene disalicylate, in feed, 20 g
100 kg−1 feed
40 (5) Probioticf in feed 40 (5) 35 −0.01 (−0.04, 0.02)
Viveros et al.
(2011)
Avoparcin, in feed, 50 mg kg−1 feed 25 (5) Grape pomace, in feed, 60 g kg−1 feed 25 (5) 20 0.0 (−0.17, 0.17)
Avoparcin, in feed, 50 mg kg−1 feed 25 (5) Grape seed extract, in feed, 7.2 g kg−1
feed
25 (5) 20 −0.08 (−0.25, 0.09)











ucm071807.htm), and consumer pressure for antibiotic-free
products, antibiotics are still used to manage some diseases.
Given the societal imperative to use antibiotics judiciously, it is
important to consider the scientific efficacy of specific antibiotics
for specific diseases as a part of the treatment decision-making
process. Based on the available scientific literature, there is no
strong scientific evidence for the efficacy of antibiotics to prevent
or treat colibacillosis in broilers. However, it is important to con-
sider that only a small volume of literature exists, and existing
trials examined heterogeneous interventions and comparison
groups. In addition, most trials had poor reporting of key trial
design features that are necessary to assess the validity of the
research. As a result, there may be some uncertainty about the
true efficacy of antibiotics for the prevention or control of coliba-
cillosis in broilers. Although there is no compelling evidence that
antibiotics are effective, there is also no compelling evidence that
they are not.
We only included controlled trials with natural disease expos-
ure in this review. For interventions where it is feasible to allocate
individuals to treatment groups, results from controlled trials pro-
vide higher evidentiary value compared to studies using an obser-
vational design (Sargeant et al., 2014a; Roudebush et al., 2004).
Challenge trials may be a useful component of the development
and validation process for an intervention, as they may provide
proof of concept for efficacy. However, the conditions of the dis-
ease challenge may not be representative of natural disease expos-
ure, and in addition, challenge trials tend to be conducted in more
controlled settings than what is typical of commercial operations
(Sargeant et al., 2014a, 2014b). Published challenge trials also
tend to result in exaggerated treatment effects compared to nat-
ural disease exposure trials evaluating the same intervention
and outcome (Egger et al., 1997; Wisener et al., 2014). This is par-
tially related to publication bias; challenge trials often involve
smaller numbers of animals than natural disease exposure trials,
and small studies are more likely to be published if they show stat-
istically significant results (Egger and Smith, 1998). Thus, small
challenge trials that show a statistically significant intervention
benefit are more likely to be published compared to small chal-
lenge trials that show no effect of the intervention. Therefore,
although challenge trials represented a larger body of literature
(73 challenge trials versus 9 trials with natural disease exposure
met the eligibility criteria for population, intervention, and out-
come) we chose not to include challenge studies in this review.
The eligible outcomes used in this review were selected based
on their importance for decision-making concerning the use of
antibiotics. The most consistently reported outcome was FCR
measured across the entire growing period. Feed conversion
ratio provides a measure of the amount of weight each bird
gains per unit of food consumed and is thus a measure of bird
performance. The antibiotic interventions examined in the trials
included in this review were intended to prevent or treat illness,
rather than for growth promotion purposes. However, FCR was
a commonly reported measure in the literature and is of import-
ance to poultry producers.
Meta-analysis can be conducted when there is a minimum of
two studies reporting the same outcome. In this review, six trials
measured FCR, but there was essentially no replication of inter-
ventions or comparison groups within the trials measuring this
outcome. The results of a single study represent one observation
within a distribution of possible study results, which may vary due
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measurements, and disease exposures between trials. Therefore,
without replication, it is not possible to evaluate whether the
results from a single study represent the true efficacy of an inter-
vention or whether the results represent an outlier (e.g. a type I
where the results suggest a statistical difference when none is pre-
sent, or a type II error result where there is an actual difference
but it is not identified in the sample population).
Comparison groups in the captured trials included treatments
with other antibiotics, non-treated controls, and alternative (non-
antibiotic) treatments. Given the importance of identifying effect-
ive alternatives to antibiotics, alternative products may be the
most appropriate control group. In this review, eligible studies
needed to include at least one antibiotic treatment arm. Since
the goal of this review was not to assess the efficacy of non-
antibiotic interventions, our search was not designed to identify
all trials evaluating the efficacy of non-antibiotic interventions.
However, future reviews could investigate the number and quality
of trials examining alternative treatments. Such reviews could
provide valuable syntheses of the existing evidence for the efficacy
of non-antibiotic interventions, which would further inform
treatment decision-making.
The results of this review highlight a number of issues related
to the completeness of reporting primary studies. These issues
included reporting of the characteristics of the trials, most notably
related to reporting of the country where the trial was conducted,
the month(s) and year of the trial, and whether the trial was con-
ducted in a commercial setting. Information on the study setting
and population(s) is necessary for the reader to make judgements
about the external validity of trial results in their own context.
Without knowledge of the specific context of a trial, a reader can-
not evaluate the various context-specific factors that might impact
the application of the research findings to other contexts.
Information on key trial design features is necessary to allow
readers to evaluate the potential for bias in the results of the trial.
Additionally, poor reporting of design features is associated with
exaggerated treatment effects (Schulz et al., 1995; Moher et al.,
1998; Burns and O’Connor, 2008; Sargeant et al., 2009a, 2009b).
The information needed to access the risk of bias in the domains
of bias included in the Cochrane Risk of Bias instrument
(Higgins et al., 2016) was not provided in any of the trials included
in this review. The Cochrane risk of bias tool was developed for
evaluating randomized controlled trials in human healthcare.
However, the general tenets of good trial design do not vary
between human and veterinary medical research. It is possible
that study authors did not conduct the trials using accepted meth-
ods for high-quality trial design, or they may have conducted the
trials with a high degree of methodological rigor, but did not report
information on key design features. Nonetheless, a reader has only
the information provided in the publication by which to access the
methodological rigor, and if that information is not available, then
the reader cannot judge the appropriateness of the approach,
methods, and ultimately the results of the study.
Deficiencies in reporting have been documented in numerous
publications examining reporting quality in food animal studies
(Wellman and O’Connor, 2007; Burns and O’Connor, 2008;
Sargeant et al., 2009a, 2009b; Brace et al., 2010; Winder et al.,
2019). The REFLECT statement was developed by an expert
consensus process in response to concerns about the quality of
Fig. 2. Forest plot to illustrate the efficacy of antibiotics compared to alternative treatments or to non-treated controlled from a systematic review on the efficacy of
antibiotics to prevent or treat colibacillosis in broiler chickens.
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reporting in clinical trials in livestock (O’Connor et al., 2010a). The
REFLECT statement consists of a 22-item checklist to provide
guidance on what should be reported in livestock trials, as well as
an explanation and elaboration document that provides additional
details for each item on the checklist. The REFLECT statement
methods and elaboration documents were co-published inmultiple
journals (O’Connor et al., 2010a, 2010b, 2010c, 2010d, 2010e;
Sargeant et al., 2010a, 2010b), and are also available online
(http://www.reflect-statement.org/; https://meridian.cvm.iastate.
edu/). Improved reporting of trials will allow readers to make a
clearer, more accurate judgement about the validity of study results.
Limitations
In searching for relevant literature, we used multiple electronic
databases, as well as some gray literature sources. However, it is
known (although difficult to document), that there is considerable
research conducted in-house within the vertically integrated
poultry industry, and the results of this research may not be pub-
licly available. Thus, it is possible that our results do not reflect
the body of research that has been conducted to evaluate the
efficacy of antibiotics for preventing or treating colibacillosis.
However, our results do reflect the publicly available literature
for decision-making by those outside of poultry groups who
conduct their own research.
Conclusions
In conclusion, based on a small volume of heterogeneous studies,
there is no strong evidence for or against the efficacy of antibiotics
to prevent or treat colibacillosis in broilers. Reporting of study
characteristics and key trial design features was generally poor
and could be improved by following recommended reporting
guidelines for controlled trials.
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